Monday, April 28, 2025

Latest

FSD Pharma Ends Class Action Lawsuit With $5.5 Million Settlement

FSD Pharma (CSE: HUGE) (NASDAQ: HUGE) this morning announced that it has settled a class action lawsuit that was filed against the firm in 2019. The class action itself was related to the build-out of its facility in Cobourg, Ontario, which in February 2019 took a turn for the worse when things fell apart with construction partner Auxly Cannabis (TSXV: XLY).

FSD this morning indicated that it has entered into a settlement agreement due to the desire to avoid the expense of court associated with forging ahead to fight the lawsuit. The company admitted no fault or liability in connection with the settlement.

Under the terms of the arrangement, the company will pay $5.5 million to settle the lawsuit, of which $4.6 million will be covered by insurance the company currently has in place. The remainder, $900,000, needs to be covered by the company directly.

To provide further clarity to our readers, this class action was filed February 22, 2019, by a shareholder of FSD whom filed a statement of claim in the Ontario Superior Court. Among other items, the claim alleged that FSD Pharma had made statements containing misrepresentations related to the build-out of the Cobourg facility.

The lawsuit was not filed by Auxly, as certain message boards seem to have misinterpretated. Rather, within regulatory filings, FSD Pharma explicitly states that “to date, neither party has taken further legal action against the counter party,” when referencing the events that transpired with Auxly.

FSD Pharma last traded at $2.14 on the CSE.


Information for this briefing was found via Sedar, and FSD Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

10 Responses

    1. I too lost over 50k and when I finally found out amd wanted to join the suit, they claimed I was a few months late to join . I don’t think that’s fair and that very shareholder should have been contacted.

  1. Have entered my name and number twice and called in regards to this class action lawsuit. Was always told I would be updated.

    I have lost over 10k from this company.

    416 389 0291

    Stef

    1. hi,
      I have lost almost $24000, since we are in the same boat and if you find any solution, kindly let me know which I will appreciate highly.
      best regards,
      kabita
      416 6253481

Leave a Reply

Video Articles

Bell Q3 Earnings: Massive Impairments. Guidance Cuts. A Mess.

Alamos Gold Q3: Record Revenue & Production Amid Rising Costs

The Junior Mining Market Is Back

Recommended

Germany Looks To Modernize Military Recruitment But Stops Short of Conscription

First Majestic Silver Posts Topline Revenue Of $146.1 Million In Q3 2024

Related News

FSD Pharma Severs Ties with Auxly Cannabis

FSD Pharma (CSE: HUGE, OTCMKTS: FSDDF) announced late last night that it had cut ties...

Thursday, February 7, 2019, 02:00:36 PM

Auxly Cannabis Shows Gross Profit For The First Time In Q1

The last time we wrote about Auxly Cannabis (TSXV: XLY), we were critical of the...

Tuesday, June 2, 2020, 10:30:00 AM

Auxly Reports Revenues of $2.31 million for Second Quarter

Auxly Cannabis (TSXV: XLY) reported its second quarter earnings for fiscal year 2019, indicating the...

Friday, August 16, 2019, 09:53:37 AM

Auxly Cannabis To Raise $15 Million In Bought Deal Financing

Auxly Cannabis (TSX: XLY) this morning announced that it is raising further funds. The firm...

Wednesday, June 9, 2021, 07:34:34 AM

Auxly Cannabis Files Notice of Foreclosure On Curative Cannabis, Begins Motions to Obtains Assets

The first notable bankruptcy in the cannabis sector appears to have taken place. On September...

Monday, September 23, 2019, 09:55:41 AM